Cannabis investors punished Canopy Growth (TSX:WEED)(NYSE:CGC) after a worse-than-expected earnings report revealing deep cracks in the industry. Canopy plunged as a result. For once, though, the drop looks less like a value opportunity than a wake-up call. But what’s the outlook for this cannabis stock, and why are investors so divided on its outlook? Let’s take a look. Is Canopy…
Read More
In an unexpected move on Tuesday, one of Canada’s largest marijuana firms Aphria (TSX:APHA)(NYSE:APHA) announced that it is moving its U.S. stock listing from the New York Stock Exchange (NYSE) to the Nasdaq Global Select Market effective on Monday, June 8. Aphria’s stock listing migration will take place soon after the firm closes its fiscal year 2020 financial books on…
Read More
Investors looking for the most secure cannabis investments for long-term upside have a few strong picks right now. Perhaps one of the strongest is Aphria (TSX:APHA)(NYSE:APHA). This name sports an appealing mix of qualities from a reassuring cash runway, upward momentum, and a strong recent performance. From its last quarterly report to its outlook, here’s what cannabis investors need to…
Read More
Everyone wants to find a multi-bagger stock. That’s an investment that could double, triple, or even quadruple in value. These opportunities aren’t easy to find, but one pot stock looks the part. Before we jump into the stock pick, it’s critical to understand the recent history of marijuana. A volatile beginning In 2018, Canada passed the Cannabis Act, which paved…
Read More
Uncertain times often lead to surprising success stories. The COVID-19 pandemic crushed entire industries, while pushing cannabis ever closer to full legitimacy. Marijuana businesses depend on innovation – something that is critical in the current environment. As COVID-19 rages, rapid-fire local legislation often disrupts traditional supply lines. Given the patchwork of laws and questionable legality in many jurisdictions, marijuana companies…
Read More
Aurora Cannabis’s (TSX:ACB)(NYSE:ACB) management is frantically rushing against time to restructure the Canadian marijuana firm’s business so as to achieve a positive operating earnings target by the third calendar quarter of 2020. The company has so far announced five disposal and acquisition transactions in May. Will the latest strategic moves help management hit near-term profitability targets? Aurora Cannabis stock price…
Read More
Pot stocks are in a world of pain. Long gone are the days of 2018, when every cannabis company was seeing its valuation explode higher. Last year, an industry-wide bear market forced marijuana stock prices down by 50%. The coronavirus pandemic of 2020 only compounded those troubles. Look at industry leaders like Cronos Group. In early 2019, the company had…
Read More
Most investors who bought Aurora Cannabis (TSX:ACB)(NYSE:ACB) common shares during the past year are still in the red, even after the recent 117% rally in Aurora Cannabis stock price over the past few trading sessions. The marijuana firm’s latest quarterly results have shown desired progress. Can we expect the positive momentum to hold for much longer, or the company is…
Read More
Altria Group (NYSE:MO) is a giant company. Now valued at $70 billion, the tobacco behemoth has advantages that smaller competitors simply don’t possess. In today’s environment, Altria’s access to capital is most prized of all. There’s a chance the company could use its power to completely acquire its cannabis partner, Cronos Group Inc (TSX:CRON)(NASDAQ:CRON). In December of 2018, Altria and Cronos…
Read More
It’s official. The cannabis bubble has definitely burst. Across the board even the biggest cannabis stocks have come crashing down. Even before the pandemic, these stocks were in trouble. Now that COVID-19 is still sweeping the world, these cannabis stocks have an incredibly long road ahead. However, there are a few signs of life out there that investors should look…
Read More